EDITAS MEDICINE INC.

Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting

10 5 2024 05:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

08 5 2024 08:49:21 提供 NetDania Notify

Editas Medicine Announces First Quarter 2024 Results and Business Updates

08 5 2024 06:00:01 提供 Nasdaq GlobeNewswire

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

02 5 2024 06:00:00 提供 Nasdaq GlobeNewswire

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

01 5 2024 07:00:01 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

25 4 2024 08:45:02 提供 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

24 4 2024 14:42:20 提供 NetDania Notify

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

22 4 2024 15:31:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

19 4 2024 08:45:22 提供 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

18 4 2024 08:45:09 提供 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

17 4 2024 08:45:46 提供 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

16 4 2024 08:45:13 提供 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

15 4 2024 09:47:30 提供 NetDania Notify

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

28 2 2024 06:00:01 提供 Nasdaq GlobeNewswire

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events

21 2 2024 06:00:00 提供 Nasdaq GlobeNewswire

Editas Medicine to Participate in Upcoming Investor Conferences

31 1 2024 08:00:00 提供 Nasdaq GlobeNewswire

Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference

08 1 2024 07:15:00 提供 Nasdaq GlobeNewswire

Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 1 2024 06:00:00 提供 Nasdaq GlobeNewswire

Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9

13 12 2023 08:00:00 提供 Nasdaq GlobeNewswire

Editas Medicine Announces New EDIT-301 Safety and Efficacy Data in 17 Patients, Presented Today at the American Society of Hematology (ASH) Annual Meeting and in a Company-sponsored Webinar

11 12 2023 11:00:00 提供 Nasdaq GlobeNewswire